Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2026年3月14日
	新闻
	Modifiable risk factors drive a large share of the global cancer burden | Nature Medicine Nature High BMI, air pollution and ultraviolet radiation played an important part in specific regions. Lung, stomach and cervical cancers together accounted ... 标记为不相关
	NCCN recommends targeted therapy for HER2-mutant advanced NSCLC | Boehringer Ingelheim US Boehringer Ingelheim Lung cancer claims more lives than any other cancer type4 and the incidence is set to increase to over 3 million cases worldwide by 2040.5 NSCLC is ... 标记为不相关
	Risk Factors That Help Inform Treatment Selection in Frontline EGFR-Mutated NSCLC OncLive ... lung cancer. Vokes discusses the impact of CNS metastases, co-mutations, tumor burden, and patient performance status on therapeutic strategy. 标记为不相关
	When EGFR meets MET: Dual blockade as the next post-TKI standard? - ScienceDirect ScienceDirect.com 5.4 months; hazard ratio 0.34) in patients with EGFR-mutated, MET-amplified non-small-cell lung cancer (NSCLC) after EGFR tyrosine kinase inhibitor ( ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈